Digital breast tomosynthesis (DBT) is a 3D breast imaging technique built on full field digital mammography technology. DBT systems create multiple projection images of the breasts obtained from different angles of the rotating X-Ray tube at a low radiation dose through the compressed breast. Images are reconstructed into multiple slices of 1mm thickness and viewed on a dedicated monitor approved for tomosynthesis. This minimizes the impact of tissue superimposition resulting in better visualization of the internal structures. Conventionally, breast screening was performed step by step, starting with full-field digital mammography (FFDM or 2D mammography) followed by digital breast tomosynthesis (3D mammography) or breast Magnetic Resonance Imaging (MRI). FFDM is considered the gold standard in breast cancer screening. However, with the advent of DBT technology, it is slowly being replaced. DBT is frequently used as an adjunct technique with FFDM. Research and studies are being undertaken to consider DBT as a primary screening tool, particularly in patients with dense breasts. 3D mammography has proven to be better than 2D mammography in multiple clinical trials, which has led to an increase in its adoption. Combination of 2D and 3D mammography has become the new standard of care since 3D mammography compliments conventional 2D mammography. The purpose of our study was to comprehensively characterize the dosimetrist properties of a clinical DBT system for the acquisition of mammographic and tomosynthesis images.
The global Digital Breast Tomosynthesis (DBT) System market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Digital Breast Tomosynthesis (DBT) System market based on company, product type, end user and key regions.
This report studies the global market size of Digital Breast Tomosynthesis (DBT) System in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Digital Breast Tomosynthesis (DBT) System in these regions.
This research report categorizes the global Digital Breast Tomosynthesis (DBT) System market by top players/brands, region, type and end user. This report also studies the global Digital Breast Tomosynthesis (DBT) System market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Hologic
GE Healthcare
Siemens
I.M.S.
PLANMED OY
XinRay Systems
FUJIFILM
Market size by Product
2D Digital Mammography Technology
3D Digital Mammography Technology
Market size by End User
Hospitals
Diagnostic Centers
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Digital Breast Tomosynthesis (DBT) System market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Digital Breast Tomosynthesis (DBT) System market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Digital Breast Tomosynthesis (DBT) System companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Digital Breast Tomosynthesis (DBT) System submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Digital Breast Tomosynthesis (DBT) System are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Digital Breast Tomosynthesis (DBT) System market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Summary:
Get latest Market Research Reports on Digital Breast Tomosynthesis (DBT) System . Industry analysis & Market Report on Digital Breast Tomosynthesis (DBT) System is a syndicated market report, published as Global Digital Breast Tomosynthesis (DBT) System Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Digital Breast Tomosynthesis (DBT) System market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.